Effects of Exercise and Insole on Foot Posture, Plantar Force Distribution, and Balance in Individuals With Pes Planus

December 12, 2021 updated by: Müge KIRMIZI, Dokuz Eylul University

Comparison of the Effects of Foot Exercise Program and Arch Support Insoles on Foot Posture, Plantar Force Distribution, and Balance in Individuals With Flexible Pes Planus

The aim is to compare the effects of intrinsic foot muscles and tibialis posterior strengthening exercise, and customized arch support insoles on foot posture, plantar force distribution, and balance in individuals with flexible pes planus.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The aim is to compare the effects of intrinsic foot muscles and tibialis posterior strengthening exercise, and customized arch support insoles on foot posture, plantar force distribution, and balance in individuals with flexible pes planus. Forty-two individuals with flexible pes planus will be recruited into the study according to the inclusion criteria. Participants will be randomly divided into three groups: (1) Exercise, (2) Insole, (3) Exercise plus Insole. Exercises will be performed three times per week for six weeks, also custom-made insoles will be worn for six weeks. Foot posture will be assessed using the Navicular drop, Valgus index and Foot posture index-6. Plantar force variables will be recorded by the pressure-sensitive mat (HR Mat, Tekscan, USA) mounted in the middle of the 6-meter walkway in three sessions: (1) Upright standing, (2) Walking at different speeds: self-selected slow, normal and fast speeds, (3) Walking just after the heel-rise test for endurance. Balance performance will be assessed by the Balance Master System (NeuroCom® International Inc., USA). The assessments will be made pre/post intervention and at 6-weeks follow-up.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Izmir, Turkey, 35340
        • Dokuz Eylul University, Institute of Health Sciences

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. being between 18 and 40 years of age,
  2. having Navicular drop test greater than 10 mm,
  3. having Foot posture index-6 greater than or equal to 6,
  4. having bilateral flexible pes planus.

Exclusion Criteria:

  1. a lack of anatomical integrity of the foot,
  2. a history of surgery or trauma in the foot region,
  3. other musculoskeletal or neurological problems which may affect balance and gait performance.
  4. having received any treatment for lower extremity disorders including pes planus within the last 1 year
  5. having a body mass index equal to or greater than 30.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Exercise
Exercises will be performed three times per week for six weeks.
Intrinsic foot muscles and tibialis posterior strengthening exercises
Experimental: Insole
Customized arch support insoles will be worn for six weeks.
Customized arch support insoles
Experimental: Exercise plus Insole
Exercises will be performed three times per week, and customized arch support will be worn for six weeks.
Intrinsic foot muscles and tibialis posterior strengthening exercises
Customized arch support insoles

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Foot posture
Time Frame: Change in foot posture measures from baseline to six weeks and to twelve weeks
Foot posture will be assessed using the Navicular drop, Valgus index and Foot posture index-6.
Change in foot posture measures from baseline to six weeks and to twelve weeks
Balance
Time Frame: Change in balance scores from baseline to six weeks and to twelve weeks
Balance performance will be assessed by the Balance Master System (NeuroCom® International Inc., USA).
Change in balance scores from baseline to six weeks and to twelve weeks
Plantar force variables
Time Frame: Change in plantar pressure variables from baseline to six weeks and to twelve weeks
Plantar force variables will be recorded by the pressure-sensitive mat (HR Mat, Tekscan, USA) mounted in the middle of the 6-meter walkway in three sessions: (1) Upright standing, (2) Walking at different speeds: self-selected slow, normal, and fast speeds, (3) Walking just after the heel-rise test for endurance.
Change in plantar pressure variables from baseline to six weeks and to twelve weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 30, 2019

Primary Completion (Actual)

July 26, 2021

Study Completion (Actual)

July 26, 2021

Study Registration Dates

First Submitted

November 24, 2019

First Submitted That Met QC Criteria

November 25, 2019

First Posted (Actual)

November 27, 2019

Study Record Updates

Last Update Posted (Actual)

January 3, 2022

Last Update Submitted That Met QC Criteria

December 12, 2021

Last Verified

December 1, 2021

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pes Planus

Clinical Trials on Exercise

3
Subscribe